Fundraising FoxH.I.G. BioHealth Partners — Full Portfolio
7 tracked investments · listed companies and verified rows first
Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.
BiotechConsumerHealthtechZug, CH
Co-investorsAndera PartnersF-Prime CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersBRV Capital ManagementEQT Life Sciences
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)
BoardAlex Zisson(Director)
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesRevelation Partners+5 more
BiotechHealthtechWayne, US
Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)
Co-investors415 CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersRunway Growth CapitalNew Enterprise Associates (NEA)Vensana Capital
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsExcel Venture ManagementNew Enterprise Associates (NEA)Sanderling VenturesH.I.G. Capital
On Target Laboratories is a company of scientists and researchers focused on cancer surgery, developing products to support surgical oncology.
BiotechHealthtechMedical Devices
Bill Peters(President, Chief Executive Officer, and Board Member)inRod MacLeod(Chief Financial Officer)inTommy Lee(Senior Vice President of Clinical Operations)inCatherine Brisson(Vice President of Regulatory Affairs and Quality)Anne Fornicola(Vice President of Chemistry, Manufacturing and Controls)inScott Huennekens(Executive Chairperson)in
Co-investors3B Future Health FundCerity Partners VenturesElevate VenturesH.I.G. CapitalH.I.G. HealthBridge Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.